Avasimibe inhibited the cholesterol esterification of CD8+ TILs rather than cancer cells and reversed the ratio of CD8+/CD4 T cells, especially decreased CD4+CD25+FOXP3+ Treg cells infiltration in the TME. This evidence concerns the gene CD4 and cancer.